Your browser doesn't support javascript.
loading
An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score.
van Deen, Welmoed K; Obremskey, Alexandra; Moore, Graham; van den Akker-van Marle, M Elske; Doctor, Jason N; Hwang, Caroline.
Afiliación
  • van Deen WK; Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai, 116 N. Robertson Blvd, PACT 800, Los Angeles, CA, 90048, USA. Welmoed.vanDeen@cshs.org.
  • Obremskey A; Gehr Family Center for Health Systems Science, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Welmoed.vanDeen@cshs.org.
  • Moore G; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • van den Akker-van Marle ME; Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Doctor JN; Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
  • Hwang C; Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA.
Qual Life Res ; 29(12): 3387-3396, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32813264
ABSTRACT

PURPOSE:

Inflammatory bowel disease (IBD) patients experience diverse symptoms and the impact of these different symptoms varies substantially. Current disease activity measures do not account for the relative importance of the different symptoms and severity levels. In this study, we aimed to quantify the relative importance of different symptoms for IBD patients and to develop a patient preference-weighted symptom (PWS) score to assess symptom burden in IBD.

METHODS:

We performed a choice-based conjoint analysis (CBCA) survey with 129 IBD patients to estimate the relative importance of four common IBD symptoms stool frequency, abdominal pain, blood in stools, and urgency. We then developed the PWS score using the preferences obtained from the CBCA, which we validated against existing measures.

RESULTS:

CBCA revealed that urgency was the most important symptom to patients, followed by abdominal pain and blood in stools. Urgency associated with incontinence received particularly high scores and was perceived to be more than 3 times as important as urgency without incontinence. Our results confirmed that different symptoms are not equally bothersome, and we showed that the relation between symptom-level and importance is not linear. The PWS score, which we developed using these estimates was highly correlated with existing disease activity measures.

CONCLUSIONS:

We quantified the relative importance of four common IBD symptoms and developed the PWS score for IBD, which takes the relative importance of different symptoms and symptom-levels into account. The PWS score can be used to obtain a patient-centered assessment of symptom burden.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Inflamatorias del Intestino Tipo de estudio: Diagnostic_studies / Qualitative_research Límite: Female / Humans / Male Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Inflamatorias del Intestino Tipo de estudio: Diagnostic_studies / Qualitative_research Límite: Female / Humans / Male Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos